Skip to content

Effect of Ropivacaine During Popliteal Nerve Block in Foot and Ankle Surgery

Randomized Study of the Effect of Initial Ropivacaine Dosage During Continuous Popliteal Nerve Blocks on Rebound Pain in Foot and Ankle Surgery

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04872322
Enrollment
128
Registered
2021-05-04
Start date
2017-08-31
Completion date
2021-12-31
Last updated
2021-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle Surgery, Foot Surgery, Popliteal Nerve Block

Brief summary

With the increasing rise of outpatient surgery in orthopaedic procedures, the management of immediate postoperative pain has been a major topic investigated, with the use of a peripheral nerve block in combination with general anesthesia being a commonly accepted method. Foot and ankle procedures, which offer the choice of several anesthetic techniques, have increasingly been performed with this method predominantly through the combination of general anesthesia with a single-injection popliteal nerve block to reduce the substantial acute postoperative pain that often requires large opioid intake within the post-anesthesia care unit (PACU). However, as a single-injection peripheral nerve block resolves off shortly following surgery, major postoperative pain, termed rebound pain, can also arise, and has the potential to be even greater than that of patients who do not receive any peripheral nerve block with general anesthesia. The purpose of this study is to evaluate the contribution of ropivacaine concentration (0.5% versus 0.25%) of the initial bolus in continuous popliteal nerve blocks toward the rebound pain phenomena, or the quantifiable difference in pain experienced during the initial time after block resolution, in foot and ankle surgeries.

Interventions

DRUGRopivacaine 0.5% Injectable Solution

Participants will receive the nerve block preoperatively using 0.5% ropivacaine

DRUGRopivacaine 0.25% Injectable Solution

Participants will receive the nerve block preoperatively using 0.25% ropivacaine

After surgery participants will be given a prescription for Percocet to be taken as needed for pain

DRUGNorco Pill

After surgery participants will be given a prescription for Norco to be taken as needed for pain

PROCEDUREFoot/Ankle Surgery

Participant will undergo foot or ankle surgery and receive a popliteal nerve block

Sponsors

Rothman Institute Orthopaedics
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* All patients undergoing foot and ankle surgeries under the care of Dr. Steven Raikin with continuous popliteal blocks at Riverview Surgical Center will be considered for enrollment.

Exclusion criteria

* Patients who present with a) known hypersensitivity to ropivacaine or to any local anesthetic agent of the amide type, * Existing use of narcotics, * Pregnant women, * Individuals under the age of 18 * Procedures involving any other forms of anesthesia other than general anesthesia with a continuous popliteal nerve block.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative Pain7 daysParticipants Satisfaction with pain control will be measured using the Visual Analog Scale for Pain (VAS)
Postoperative Opioid Usage7 daysFor each group, participants will be asked to record their postoperative pain medication usage daily

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026